review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Salma K Jabbour | |
Akshar N Patel | |||
Inaya Ahmed | |||
John L Nosher | |||
Rebecca Moss | |||
Philip G Murillo | |||
Vyacheslav Gendel | |||
P2860 | cites work | Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors | Q33305397 |
Phase I study of individualized stereotactic body radiotherapy of liver metastases. | Q33383521 | ||
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy | Q33385648 | ||
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature | Q33502056 | ||
Ablative therapies for colorectal liver metastases: a systematic review | Q33937325 | ||
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases | Q34059726 | ||
Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis | Q34429210 | ||
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. | Q34658519 | ||
Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview | Q35832101 | ||
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers | Q35979752 | ||
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial | Q36063466 | ||
Microwave ablation: principles and applications. | Q36287678 | ||
Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation | Q36631312 | ||
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI). | Q36642970 | ||
Drug-eluting particles for interventional pharmacology. | Q37197739 | ||
Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases | Q37339616 | ||
Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study | Q37353563 | ||
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors | Q37373799 | ||
Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update | Q37391183 | ||
Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer | Q37467967 | ||
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases | Q83412928 | ||
Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases | Q84617827 | ||
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol | Q85010584 | ||
Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience | Q37587013 | ||
Radiotherapy for liver metastases: a review of evidence | Q37979325 | ||
Current status of embolic agents for liver tumor embolization | Q38027067 | ||
Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up | Q38054681 | ||
Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review | Q38124073 | ||
Intra-arterial therapies for metastatic colorectal cancer | Q38179343 | ||
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study | Q39630468 | ||
Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study. | Q40301411 | ||
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial | Q40649086 | ||
Cryosurgical ablation of hepatic colorectal metastases. | Q42638641 | ||
Irreversible electroporation for treatment of liver cancer. | Q42781041 | ||
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | Q43010373 | ||
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results | Q44426543 | ||
Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients | Q44441242 | ||
Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many? | Q44519652 | ||
Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study | Q44637547 | ||
Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases | Q44794355 | ||
Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies | Q45055043 | ||
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer | Q45119871 | ||
Hepatic arterial infusion after liver resection | Q45270082 | ||
Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. | Q46011640 | ||
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis | Q46159777 | ||
Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial | Q47862162 | ||
Liver disease induced by radioembolization of liver tumors: description and possible risk factors | Q47925759 | ||
Radio-frequency ablation of colorectal liver metastases in 167 patients | Q48820048 | ||
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases | Q49186620 | ||
Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases | Q50153921 | ||
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. | Q51043928 | ||
Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. | Q51093391 | ||
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. | Q51204089 | ||
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". | Q51296233 | ||
Hepatic radiofrequency ablation. | Q51722096 | ||
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. | Q51840650 | ||
Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. | Q52930698 | ||
Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. | Q53326350 | ||
Phase II study on stereotactic body radiotherapy of colorectal metastases. | Q53687868 | ||
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. | Q54401988 | ||
Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients | Q71783537 | ||
Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma | Q74081538 | ||
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients | Q74543135 | ||
Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer | Q77125611 | ||
Radiofrequency ablation for unresectable hepatic tumors | Q77625958 | ||
Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases | Q79196755 | ||
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases | Q79465276 | ||
Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancer | Q79829253 | ||
Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management | Q80152879 | ||
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases | Q81124780 | ||
Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients | Q83129757 | ||
P433 | issue | 2 | |
P304 | page(s) | 224-240 | |
P577 | publication date | 2015-04-01 | |
P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
P1476 | title | Non-operative therapies for colorectal liver metastases | |
P478 | volume | 6 |
Q90443973 | Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018) |
Q37744386 | Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis |
Q90664385 | Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors |
Search more.